Clinical Trial Update: Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing bivalirudin/prasugrel with abciximab/clopidogrel in patients with ST-elevation myocardial infarction undergoing primary PCI, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Angiomax (bivalirudin)
• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)
• ReoPro (abciximab)

Snippet

Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Conditions: ST-Elevation Myocardial Infarction, Primary Percutaneous Coronary Intervention | Phase 4 | Status: UNKNOWN